14
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0391 |
Linezolid
PNU-100766,雷奈佐利 |
MAO; Antibacterial; Antibiotic | Metabolism; Microbiology/Virology; Neuroscience |
Linezolid (PNU-100766) 是恶唑烷酮类合成抗生素,抑制细菌蛋白质合成的起始阶段,具有抗感染作用。 | |||
T11853 |
Linezolid-d3
Linezolid D3,PNU-100766 D3 |
Others | Others |
Linezolid D3, a deuterium-labeled version of Linezolid, is a synthetic antibiotic designed to halt the initiation of bacterial protein synthesis. | |||
T39154 |
Demethyl linezolid
|
||
Demethyl linezolid is an impurity observed in linezolid, an antimicrobial compound. It exhibits effective antimicrobial properties against various human and veterinary pathogens. | |||
T12627 |
(R)-Linezolid
(R)-PNU-100766 |
Others | Others |
(R)-Linezolid is an impurity of Linezolid . Linezolid acts by inhibiting the initiation of bacterial protein synthesis. | |||
T19645 |
PNU-100440
(5R)-3-[3-氟-4-(4-吗啡啉基)苯基]-5-羟甲基-2-恶唑烷酮 |
Others | Others |
PNU-100440 是一种生物活性化合物。它是合成利奈唑胺二聚物的中间体,利奈唑胺二聚物是抗菌剂利奈唑胺的杂质。 | |||
T4165 |
Delpazolid
LCB01-0371 |
Antibacterial; Antibiotic | Microbiology/Virology |
Delpazolid (LCB01-0371) 是一种恶唑烷酮类新型抗生素,能抑制MSSA 和MRSA 的生长,对它们的MIC90值都为 2 μg/mL。 | |||
T16718 |
Radezolid
RX-1741,雷得唑来 |
Antibacterial; Antibiotic | Microbiology/Virology |
Radezolid (RX-1741) 是一种噁唑烷酮类抗生素。它对衣原体,军团菌葡萄球菌,和Linezolid 耐药菌株有活性。 | |||
T37841 |
PNU 142300
|
||
PNU 142300 is an inactive metabolite of the oxazolidinone antibiotic linezolid . | |||
T37465 |
CAY10742
|
||
CAY10742 is an orally bioavailable oxadiazole antibiotic.1It is active against the Gram-positive bacteriaS. aureus,S. epidermidis,S. haemolyticus,B. cereus,B. licheniformis,E. faecalis, andE. faecium(MICs = 1-4 μg/ml), including laboratory strains and clinical isolates with varying degrees of resistance to methicillin, vancomycin, linezolid, and other antibiotics. CAY10742 (40 mg/kg) reduces the number of bacteria in mouse neutropenic thigh models of linezolid-sensitive or -resistant methicillin... | |||
T69176 |
YycG inhibitor 16
|
||
YycG inhibitor 16 is a novel YycG inhibitor, inhibiting planktonic cells of E. faecalis, including the vancomycin- or linezolid-resistant strains. | |||
T23947 |
DA-7867
UNII-491MT9GU8K,DA 7867,DA7867 |
||
DA-7867 is a novel oxazolidinone. DA-7867 had the lowest MIC for 90% of the aerobic gram-positive bacterial strains tested (≤0.25 μg/ml) and it was more potent than linezolid. DA-7867 was the most active drug with a MIC(90) of 0.125 μg/ml. | |||
T27964 |
Voxvoganan
LTX109,Lytixar,LTX-109,LTX 109 |
||
Lytixar is a Synthetic Antimicrobial Peptide, it shows activity against Daptomycin-Nonsusceptible, Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, and Linezolid-Nonsusceptible Staphylococcus aureus. LTX-109 demonstrated a MIC range o | |||
T76990 | Suvratoxumab | ||
Suvratoxumab (MEDI4893) 是一种长效且具有亲和力高的人源化抗 α-毒素单克隆抗体(IgG1κ 型)。Suvratoxumab 能有效中和 α-毒素 (一种关键的金黄色葡萄球菌毒力因子)。Suvratoxumab 可提高免疫功能低下的小鼠肺炎模型的存活率并减少肺损伤。Suvratoxumab 还可增强Vancomycin 或Linezolid 的抗菌活性。 | |||
T23451 |
Tedizolid HCl (856866-72-3 free base)
Tedizolid HCl |
Others | Others |
Tedizolid HCl is a reversible, novel oxazolidinone antibiotic (IC50: for MAO-A (monoamine oxidase-A), 8.7 uM; for MAO-B, 5.7 uM). It is the first oxazolidinone to be approved since linezolid in 2000. Tedizolid phosphate is the second commercially availabl |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN6603 |
(S)-N-Glycidylphthalimide
(S)-N-缩水甘油邻苯二甲酰亚胺,2-[(2S)-2-Oxiranylmethyl]-1H-isoindole-1,3(2H)-dione |
Others | Others |
(S)-N-Glycidylphthalimide (2-[(2S)-2-Oxiranylmethyl]-1H-isoindole-1,3(2H)-dione) 是一种邻苯二甲酰亚胺衍生物,用作制备抗生素利奈唑胺的中间体。 |